Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » NeoGenomics Preliminary Q1 Revenues Increase 11 Percent; Firm Withdraws 2020 Guidance

NeoGenomics Preliminary Q1 Revenues Increase 11 Percent; Firm Withdraws 2020 Guidance

Apr 09, 2020
|
staff reporter

NEW YORK – NeoGenomics reported on Thursday that its preliminary revenues for the first quarter of 2020 are expected to increase 11 percent year over year to $106 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Not Quite There Yet

According to CNBC, Pfizer has announced that its SARS-CoV-2 vaccine data won't be ready this week.

Call for Open Science

A number of United Nations agencies push for scientific findings to be made accessible through open science.

Accolades for a New University

Paris-Saclay University garners international regard following a decade-long effort to establish the new research university, Nature News reports.

Nucleic Acids Research Papers on IndiGenomes, DockCoV2, ViruSurf Databases

In Nucleic Acids Research this week: database to house IndiGen sequencing data, database of SARS-CoV-2 docking scores, and more.

What's Popular?

In Business News

  1. Biodesix Prices $72M IPO

  2. Agena Bioscience Gets FDA Emergency Use Authorization for MassArray Coronavirus Test

  3. Exact Sciences Aiming to Make Pan-Cancer Blood Screening Part of Standard Medical Care

    Premium

  4. Qiagen Reports 26 Percent Q3 Revenue Growth; Ups Full-Year Guidance

  5. Exact Sciences to Acquire Thrive Earlier Detection for up to $2.15B; Q3 Revenues Spike 87 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.